
(2) Four of 72 patients with aplastic anemia who were treated with
filgrastim developed myelodysplastic syndrome (Kaito et al, 1998).
2. OUTCOME
a. Severe (mortality reported).
(1) Of 4 patients, 2 died without leukemic transformation and 2
developed acute leukemia (Kaito et al, 1998).
3. ASSOCIATED SYMPTOMS
a. Monosomy 7 (Kaito et al, 1998).
4. ONSET DURATION
a. EARLIEST ONSET: 12 months (Kaito et al, 1998).
b. LATEST ONSET: 20 months (Kaito et al, 1998).
c.